• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本呼吸学会声明:COVID-19 大流行期间 COPD 的工作诊断和初始管理。

Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic.

机构信息

Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.

Department of Respiratory Medicine, Nara Medical University School of Medicine, Nara, 634-8521, Japan.

出版信息

Respir Investig. 2021 Jul;59(4):385-388. doi: 10.1016/j.resinv.2021.03.004. Epub 2021 Apr 6.

DOI:10.1016/j.resinv.2021.03.004
PMID:33893068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8023148/
Abstract

The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pandemic has made it difficult for many clinics to perform spirometry as it may lead to possible aerosol infections. Thus, the diagnosis of COPD, especially in the early stage, has become difficult. To overcome this situation, JRS issued a "Flowchart of Working Diagnosis and Management of COPD during the COVID-19 Pandemic". This flowchart may help physicians provisionally diagnose COPD patients without performing spirometry, offering them appropriate intervention even in epidemic and pandemic situations.

摘要

日本呼吸学会(JRS)推荐使用肺活量计进行呼吸疾病的诊断。它对于慢性阻塞性肺疾病(COPD)诊断中肺活量计确认气流阻塞是不可或缺的。然而,2019 年冠状病毒病(COVID-19)大流行使得许多诊所难以进行肺活量计检查,因为这可能导致气溶胶感染的风险。因此,COPD 的诊断,特别是在早期阶段,变得更加困难。为了克服这种情况,JRS 发布了一份“COVID-19 大流行期间 COPD 的工作诊断和管理流程图”。该流程图可能有助于医生在不进行肺活量计检查的情况下对 COPD 患者进行临时诊断,即使在流行和大流行期间,也能为他们提供适当的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c09f/8023148/fe3615ecb4f8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c09f/8023148/fe3615ecb4f8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c09f/8023148/fe3615ecb4f8/gr1_lrg.jpg

相似文献

1
Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic.日本呼吸学会声明:COVID-19 大流行期间 COPD 的工作诊断和初始管理。
Respir Investig. 2021 Jul;59(4):385-388. doi: 10.1016/j.resinv.2021.03.004. Epub 2021 Apr 6.
2
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.慢性阻塞性肺疾病稳定期的诊断与管理:美国医师学会、美国胸科学会、美国胸科学会和欧洲呼吸学会的临床实践指南更新。
Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
3
The reasons for triple therapy in stable COPD patients in Japanese clinical practice.日本临床实践中稳定期慢性阻塞性肺疾病患者三联疗法的原因。
Int J Chron Obstruct Pulmon Dis. 2015 Jun 4;10:1053-9. doi: 10.2147/COPD.S79864. eCollection 2015.
4
Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.即时床旁肺功能检测在慢性阻塞性肺疾病住院患者诊疗中的应用。
Lung. 2020 Feb;198(1):143-150. doi: 10.1007/s00408-019-00314-4. Epub 2020 Jan 1.
5
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.心力衰竭合并慢性阻塞性肺疾病患者的诊断和治疗差距。
JACC Heart Fail. 2019 Oct;7(10):823-833. doi: 10.1016/j.jchf.2019.05.009. Epub 2019 Sep 11.
6
Role of Long-Acting Muscarinic Antagonist/Long-Acting β-Agonist Therapy in Chronic Obstructive Pulmonary Disease.长效毒蕈碱拮抗剂/长效β受体激动剂疗法在慢性阻塞性肺疾病中的作用
Ann Pharmacother. 2017 Aug;51(8):696-705. doi: 10.1177/1060028017705149. Epub 2017 Apr 14.
7
GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.实践中的 GOLD:初级保健环境中的慢性阻塞性肺疾病治疗和管理。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:289-299. doi: 10.2147/COPD.S222664. eCollection 2021.
8
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.伴有轻度气流受限的慢性阻塞性肺疾病:当前认知与未来研究建议——六家科学学会的共识文件
Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017.
9
Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.肺量计在慢性阻塞性肺疾病诊断中的应用及改善医疗质量的努力。
Transl Res. 2009 Sep;154(3):103-10. doi: 10.1016/j.trsl.2009.06.003. Epub 2009 Jul 8.
10
[Outline of JRS COPD guideline Ed. 4].[日本呼吸学会慢性阻塞性肺疾病指南第4版大纲]
Nihon Rinsho. 2016 May;74(5):728-32.

引用本文的文献

1
Impact of coronavirus disease 2019 on respiratory care in Japan: A nationwide survey by the Japanese Respiratory Society.新型冠状病毒病 2019 对日本呼吸照护的影响:日本呼吸学会的全国性调查。
Respir Investig. 2022 Sep;60(5):640-646. doi: 10.1016/j.resinv.2022.04.011. Epub 2022 May 23.
2
Two cases of chronic obstructive pulmonary disease evaluated by dynamic-ventilatory digital radiography for pulmonary function and assessment of treatment efficacy.动态通气数字 X 射线摄影评估慢性阻塞性肺病的两例病例,用于肺功能和治疗效果评估。
Respir Investig. 2021 Nov;59(6):871-875. doi: 10.1016/j.resinv.2021.07.005. Epub 2021 Aug 22.

本文引用的文献

1
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
2
Aerosol Transmission of SARS-CoV-2: Physical Principles and Implications.SARS-CoV-2 的气溶胶传播:物理原理及意义。
Front Public Health. 2020 Nov 23;8:590041. doi: 10.3389/fpubh.2020.590041. eCollection 2020.
3
COVID-19 and COPD.新型冠状病毒肺炎(COVID-19)与慢性阻塞性肺疾病(COPD)。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
4
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
5
COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.意大利儿科患者 COVID-19 疾病严重程度的危险因素。
Pediatrics. 2020 Oct;146(4). doi: 10.1542/peds.2020-009399. Epub 2020 Jul 14.
6
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.慢性阻塞性肺疾病的药物治疗。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69. doi: 10.1164/rccm.202003-0625ST.
7
Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.日本普通人群中自我评分的持续性气流受限筛查问卷的开发:久山研究
Int J Chron Obstruct Pulmon Dis. 2017 May 15;12:1469-1481. doi: 10.2147/COPD.S130453. eCollection 2017.
8
Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.慢性阻塞性肺疾病筛查问卷的验证及日本普通人群诊断切点的确定:久山研究
Allergol Int. 2015 Jan;64(1):49-53. doi: 10.1016/j.alit.2014.06.002. Epub 2014 Dec 17.
9
Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study.日本健康人群中吸烟习惯与气流受限的关系:高幡研究
Intern Med. 2010;49(15):1489-99. doi: 10.2169/internalmedicine.49.3364. Epub 2010 Aug 2.
10
Development and first validation of the COPD Assessment Test.COPD 评估测试的制定与首次验证。
Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.